APML

Synectic Solutions, Inc. Awarded $39M Weapons Integration Logistics Support Contract From NAVAIR NAWCAD

Retrieved on: 
Tuesday, February 13, 2024
Acquisition, System of systems, Naval aviation, NAVAIR, PMA, SSI, Missile, SoS, Defense, Lead, PSM, PEO, CONOPS, APML, Support, IPT, Combat support, Navy

The support services contract provides Integrated Product Support program management and logistics support services in acquisition and sustainment for the life cycle of specified weapons systems, System of Systems (SoS), sub-systems, and Support Equipment (SE) for the Product Support Management/Integration (PSMI) department, and the Program Offices associated with PEO U/W and PMA-259.

Key Points: 
  • The support services contract provides Integrated Product Support program management and logistics support services in acquisition and sustainment for the life cycle of specified weapons systems, System of Systems (SoS), sub-systems, and Support Equipment (SE) for the Product Support Management/Integration (PSMI) department, and the Program Offices associated with PEO U/W and PMA-259.
  • These services will support multiple logistics functional leads, including logistics Integration Department, Program Office Product Support Managers (PSM), Assistant Program Manager for Logistics (APML)/Military Lead, respective Platform Principal APMLs, respective IPT Deputy APMLs (DAPMLs), Logistics Element Managers (LEMs), and Fleet staffs (Resident Independent Logistics Support Detachment - RILSD).
  • PSMI supports the NAVAIR acquisition and sustainment process for Naval Aviation weapons systems by providing trained logistics personnel for the execution of NAVAIRs Competency Aligned Organization (CAO) Concept of Operations (CONOPS).
  • This contract holds a potential value of approximately $39 million, starting February 2024 through February 2029.

Clinical whole genome sequencing test developed at The Jackson Laboratory

Retrieved on: 
Friday, September 15, 2023
Hospice and palliative medicine, DNA, CAP, Genome, Genetic distance, DSM-IV codes, APML, Jackson Laboratory, CLIA, Protein, Patient, JAX, Education minister, Diagnosis, Disease, Antibiotics, Vaccine

A decade ago, sequencing centers began offering clinical whole exome sequencing, but these only cover the portion of the genome that codes for proteins – approximately 1.5 percent of the entire genome.

Key Points: 
  • A decade ago, sequencing centers began offering clinical whole exome sequencing, but these only cover the portion of the genome that codes for proteins – approximately 1.5 percent of the entire genome.
  • To improve the diagnostic power of sequencing and identify the genetic basis of disease, the Advanced Precision Medicine Laboratory (APML) at The Jackson Laboratory for Genomic Medicine (JAX) in Farmington, Connecticut, is offering a fully validated, clinical whole genome sequencing test.
  • The APML is CLIA certified and CAP accredited and the JAX Genome test is the only clinical whole genome sequencing test currently offered in Connecticut.
  • The JAX Genome test includes DNA extraction from whole blood, sequencing of the genome, and variant analysis and interpretation.